Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Pages: S1 - S33 Abstract: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, Volume 156, Issue 5, Page S1-S33, September/October 2023.
Citation: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada PubDate: 2023-09-07T04:40:09Z DOI: 10.1177/17151635231196198 Issue No:Vol. 156, No. 5 (2023)
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors:Lindsay Rodwell, Sadaf Faisal Pages: 240 - 242 Abstract: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, Volume 156, Issue 5, Page 240-242, September/October 2023.
Citation: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada PubDate: 2023-09-07T04:40:10Z DOI: 10.1177/17151635231193481 Issue No:Vol. 156, No. 5 (2023)
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors:William Semchuk, Claudia Bucci Abstract: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, Ahead of Print.
Citation: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada PubDate: 2023-08-17T05:32:08Z DOI: 10.1177/17151635231191491
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors:Jaris Swidrovich Abstract: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, Ahead of Print.
Citation: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada PubDate: 2023-07-31T05:26:36Z DOI: 10.1177/17151635231188964
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors:Sherilyn K.D. Houle, Mhd. Wasem Alsabbagh, Nancy M. Waite Abstract: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, Ahead of Print. Background:Due to workload and competing priorities, vaccination-related interactions in community pharmacies tend to be more reactive than proactive. The aim of this study is to determine the proportion of users of a web-based scheduling system for influenza and COVID-19 vaccines who may be eligible for herpes zoster or human papillomavirus (HPV) vaccination and interested in discussing these vaccines with a pharmacist.Methods:Individuals scheduling an influenza or COVID-19 vaccine at a pharmacy using the MedEssist platform between October 2021 and March 2022 were asked about their vaccination status against HPV (if aged 9-45) or herpes zoster (if aged ≥50). Those who were unvaccinated or unsure were asked to indicate their willingness to discuss this with a pharmacist. Logistic regression was performed to identify patient characteristics associated with responses to these screening questions.Results:Among 36,659 bookings by those aged 9 to 45 and 55,728 by those aged ≥50 that included responses to screening questions, 70.1% and 55.5% were potentially unvaccinated against HPV and herpes zoster, respectively, with approximately 1 in 5 also indicating willingness to have a discussion with the pharmacist. Those scheduling appointments for COVID-19 vaccines were significantly less likely to be vaccinated against HPV or herpes zoster and less willing to discuss this with a pharmacist than those seeking influenza vaccination.Discussion:Automated prompts while booking influenza or COVID-19 vaccinations have the potential to identify vaccine-willing individuals who may benefit from further discussion on their vaccination needs.Conclusion:Community pharmacies can leverage available technology to support the efficient and effective identification of individuals eligible for vaccination. Citation: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada PubDate: 2023-07-31T05:23:46Z DOI: 10.1177/17151635231188343
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors:Zubin Austin, Ross T. Tsuyuki Abstract: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, Ahead of Print.
Citation: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada PubDate: 2023-07-27T06:36:15Z DOI: 10.1177/17151635231189226
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors:Christopher Evernden, Theresa L. Charrois Abstract: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, Ahead of Print.
Citation: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada PubDate: 2023-07-27T06:32:35Z DOI: 10.1177/17151635231188347
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors:Annissa Fung, Anne Truong, Maria Anwar Abstract: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, Ahead of Print.
Citation: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada PubDate: 2023-07-27T06:27:55Z DOI: 10.1177/17151635231188339
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors:Derek Jorgenson, Katelyn Halpape Abstract: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, Ahead of Print. Background:Chronic noncancer pain (CNCP) is a common condition that affects individuals at a biopsychosocial level and can significantly impair function and quality of life. Referral to an interprofessional CNCP program is recommended for most patients; however, these clinics are limited in number and capacity. Expanding access by testing new service delivery models would be of value. The purpose of this study was to measure the impact of a new pharmacist-led, interprofessional model of care developed at the University of Saskatchewan Chronic Pain Clinic.Methods:A retrospective chart audit was conducted using data that included adult patients referred for CNCP management between May 2020 and December 2021. Medication use, overall health status (using the Clinical Global Impression of Change–Improvement [CGI-I] scale) and patient readiness to change (using the Transtheoretical Model) were measured 6 months after the initial appointment.Results:The study included 138 patients. Of the 80 patients taking an opioid, 22.5% were switched to buprenorphine/naloxone and the remainder had their mean morphine-equivalent dose reduced by a mean of 41.7 mg/d. Overall patient health status was minimally improved and many patients moved into the Action stage of change.Discussion:Changes in opioid use demonstrate a clinically important shift toward safer medication regimens that are less likely to lead to toxicity and unintended overdose. CGI-I data suggest that these patients, whose health status is typically very difficult to change, did not deteriorate but slightly improved after attending the clinic.Conclusion:The unique pharmacist-led, interprofessional model of care used by the University of Saskatchewan Chronic Pain Clinic may offer a viable alternative to traditional physician-led models. Citation: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada PubDate: 2023-07-26T06:44:57Z DOI: 10.1177/17151635231188334
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors:Alex J. Adams Abstract: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, Ahead of Print.
Citation: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada PubDate: 2023-07-26T06:43:57Z DOI: 10.1177/17151635231188330
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors:Chelsea Geen Abstract: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, Ahead of Print.
Citation: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada PubDate: 2023-07-25T06:18:19Z DOI: 10.1177/17151635231188340
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors:Jaclyn Tran, Connor Shaffelburg, Emma Phelan, Heather Neville, Allison Lively, Penelope Poyah, Karthik Tennankore, Keigan More, Steven Soroka, Diane Harpell, Jo-Anne Wilson Abstract: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, Ahead of Print. Background:The kidneys are responsible for the elimination of many drugs. Chronic kidney disease (CKD) is common, and medications may require adjustment to avoid adverse outcomes. Despite the availability of kidney drug dosing resources, people with CKD are at risk of inappropriate drug prescribing. Community pharmacists are in the ideal position to mitigate harm from inappropriate prescribing in this population.Methods:In this qualitative study, community pharmacists were interviewed on their perspective on kidney function assessment and dose adjustment in people with advanced CKD (estimated glomerular filtration rate Citation: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada PubDate: 2023-07-07T08:13:24Z DOI: 10.1177/17151635231176530
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Abstract: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, Ahead of Print.
Citation: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada PubDate: 2022-04-19T12:45:34Z DOI: 10.1177/17151635221098004
Hybrid journal (It can contain Open Access articles)
